Evidence map›Paper›PMID 35806259›Full record

ReviewInternational journal of molecular sciences2022

Research Progress on the Preparation and High-Value Utilization of Lignin Nanoparticles.

Kefeng Liu, Yuntang Zhuang, Jiachuan Chen, Guihua Yang, Lin Dai

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kefeng LiuKey Laboratory of Pulp and Paper Science & Technology of Ministry of Education, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.
Yuntang ZhuangState Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.
Jiachuan ChenState Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.
Guihua YangState Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.ORCID 0000-0003-0743-6213
Lin DaiCollege of Light Industry and Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.ORCID 0000-0001-7564-5450

Funding

Innovation and entrepreneurship training program for college students in Shandong Province S202010431056National Key Research and Development Program of China 2019YFC1905904National Natural Science Foundation of China 31901267, 31901273Provincial Key Research and Development Program of Shandong 2021CXGC010601State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Tech-nology, Shandong Academy of Sciences ZZ20200105
6 · The paper itself

Abstract

Lignin nanoparticles, the innovative achievements in the development and utilization of lignin, combine the structural characteristics of nanomaterials and lignin molecules and have a wide range of applications. In this review, we summarize the methods for preparing lignin nanoparticles by solvent exchange method, mechanical method, biological enzymatic method, interface polymerization/crosslinking method, and spray freezing method, and emphatically introduce the application prospects of lignin nanoparticles in ultraviolet protection, antibacterial, nano-filler, drug delivery, and adsorption, aiming to provide a certain reference direction for additional high-value applications of lignin nanoparticles.

Indexed as

NanoparticlesNanostructuresChemical PhenomenaLigninPolymerizationLigninhigh-value utilizationligninnanoparticlespreparation methods

Identifiers

PMID35806259
PMCPMC9266533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.